Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Protective Effects of Withania Somnifera Against Cisplatin-Induced Acute Kidney Injury in Rats: A Histomorphometric Analysis

View through CrossRef
Objective: This research aims to analyze the toxic effects of cisplatin and its amelioration by the root extract of Withania Somnifera on acute kidney injury in rat models through histomorphometric parameters.Study Design:  Experimental study.Place and Duration of Study: The study was conducted at the Department of Anatomy and Animal House, Baqai Medical University Karachi, Pakistan, from November 2018 to February 2019.Methods: 80 adult male Albino Wistar rats split evenly into four groups for study purposes. No intervention was administered to Group A (control group), and Group B (treatment group) was given intraperitoneal injections of Cisplatin at 1mg/kg daily for 7 days. Group C (protected group) received ethanolic extract of Withania somnifera roots in an oral dose of 500mg/kg for 15 days before cisplatin treatment and continued with it till 22nd day. Group D (positive control group) was exclusively given Withania somnifera root extract 500mg/kg orally for 22 days’ duration. Group B was anesthetized & sacrificed on the 8th day of study, while groups A, C, and D at the 23rd day. Kidneys from all sacrificed animals were carefully dissected and harvested for subsequent histomorphological analysis. This included analysis of Proximal convoluted tubule (PCT) count & PCT cell count under a microscope. Data were analyzed using SPSS version 22. One-way ANOVA was performed to compare groups, followed by post-hoc Tukey's test to assess the group differences.Results: The final kidney weight of rats in cisplatin-treated group B showed a significant increase (P<0.05) as compared to groups C & D. However, no statistically significant differences in kidney weight were observed among the other groups (P>0.05). Microscopic examination of Group B kidneys revealed significant (P<0.05) histopathological changes in renal parenchyma. There was a decrease in the mean Proximal convoluted tubule count and Proximal convoluted tubule cell count of Cisplatin treated group.  In contrast, Group C displayed preserved renal architecture (P>0.05).Conclusion: This study concluded that pretreatment with Withania Somnifera root extract attenuates cisplatin-induced acute kidney injury, mediated by its antioxidant and anti-inflammatory properties. Histomorphological analysis revealed significant improvements in proximal tubule (PCT) count & PCT Cell count per reticule. Withania Somnifera also reduced kidney weight, which was increased due to renal parenchymal edema associated with cisplatin-induced inflammation.  How to cite this: Rasheed A, Younus N, Jamshed N, Faisal L, Waseem N, Zeeshan RM, Shamim O. Protective Effects of Withania Somnifera Against Cisplatin-Induced Acute Kidney Injury in Rats: A Histomorphometric Analysis. Life and Science. 2025; 6(1): 36-43. doi: http://doi.org/10.37185/LnS.1.1.661
Title: Protective Effects of Withania Somnifera Against Cisplatin-Induced Acute Kidney Injury in Rats: A Histomorphometric Analysis
Description:
Objective: This research aims to analyze the toxic effects of cisplatin and its amelioration by the root extract of Withania Somnifera on acute kidney injury in rat models through histomorphometric parameters.
Study Design:  Experimental study.
Place and Duration of Study: The study was conducted at the Department of Anatomy and Animal House, Baqai Medical University Karachi, Pakistan, from November 2018 to February 2019.
Methods: 80 adult male Albino Wistar rats split evenly into four groups for study purposes.
No intervention was administered to Group A (control group), and Group B (treatment group) was given intraperitoneal injections of Cisplatin at 1mg/kg daily for 7 days.
Group C (protected group) received ethanolic extract of Withania somnifera roots in an oral dose of 500mg/kg for 15 days before cisplatin treatment and continued with it till 22nd day.
Group D (positive control group) was exclusively given Withania somnifera root extract 500mg/kg orally for 22 days’ duration.
Group B was anesthetized & sacrificed on the 8th day of study, while groups A, C, and D at the 23rd day.
Kidneys from all sacrificed animals were carefully dissected and harvested for subsequent histomorphological analysis.
This included analysis of Proximal convoluted tubule (PCT) count & PCT cell count under a microscope.
Data were analyzed using SPSS version 22.
One-way ANOVA was performed to compare groups, followed by post-hoc Tukey's test to assess the group differences.
Results: The final kidney weight of rats in cisplatin-treated group B showed a significant increase (P<0.
05) as compared to groups C & D.
However, no statistically significant differences in kidney weight were observed among the other groups (P>0.
05).
Microscopic examination of Group B kidneys revealed significant (P<0.
05) histopathological changes in renal parenchyma.
There was a decrease in the mean Proximal convoluted tubule count and Proximal convoluted tubule cell count of Cisplatin treated group.
 In contrast, Group C displayed preserved renal architecture (P>0.
05).
Conclusion: This study concluded that pretreatment with Withania Somnifera root extract attenuates cisplatin-induced acute kidney injury, mediated by its antioxidant and anti-inflammatory properties.
Histomorphological analysis revealed significant improvements in proximal tubule (PCT) count & PCT Cell count per reticule.
Withania Somnifera also reduced kidney weight, which was increased due to renal parenchymal edema associated with cisplatin-induced inflammation.
  How to cite this: Rasheed A, Younus N, Jamshed N, Faisal L, Waseem N, Zeeshan RM, Shamim O.
Protective Effects of Withania Somnifera Against Cisplatin-Induced Acute Kidney Injury in Rats: A Histomorphometric Analysis.
Life and Science.
2025; 6(1): 36-43.
doi: http://doi.
org/10.
37185/LnS.
1.
1.
661.

Related Results

Hematological and Histomorphological Amelioration by Withania Somnifera of Cisplatin-induced Splenotoxicity in Rats
Hematological and Histomorphological Amelioration by Withania Somnifera of Cisplatin-induced Splenotoxicity in Rats
Objective: This study was designed to analyse the toxic effects of the anti-cancer drug cisplatin on rat spleen and blood parameters and its amelioration by the root extract of a n...
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
RAD51C is a RAD51 paralog protein that mediates RAD51 filament formation on single-stranded DNA (ssDNA) in a canonical homologous recombination (HR) pathway. This step is vital for...
MIRACLE AYURVEDIC HERB - ASHWAGANDHA (WITHANIA SOMNIFERA DUNAL)
MIRACLE AYURVEDIC HERB - ASHWAGANDHA (WITHANIA SOMNIFERA DUNAL)
Ayurveda is successfully implemented as a primary healthcare system in India, and it is flourishing in the promotion of health around the world. Ayurveda aims to create a society h...
The effects of recombinant klotho in cisplatin‐induced ovarian failure in mice
The effects of recombinant klotho in cisplatin‐induced ovarian failure in mice
AbstractAimTo investigate whether recombinant klotho given concomitantly with cisplatin is effective in preventing cisplatin‐induced ovarian damage.MethodsThirty‐two adult female m...
Progression of Cisplatin-Induced Nephrotoxicity in a Carnitine-Depleted Rat Model
Progression of Cisplatin-Induced Nephrotoxicity in a Carnitine-Depleted Rat Model
<i>Background:</i> This study has been initiated to investigate whether endogenous carnitine depletion and/or carnitine deficiency is an additional risk factor and/or a...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
NEUROPROTECTIVE PROPERTIES OF WITHANIA SOMNIFERA - THERAPEUTIC POTENTIAL IN ALZHEIMER'S AND PARKINSON'S DISEASE
NEUROPROTECTIVE PROPERTIES OF WITHANIA SOMNIFERA - THERAPEUTIC POTENTIAL IN ALZHEIMER'S AND PARKINSON'S DISEASE
Introduction: Withania somnifera (ashwagandha) is a medicinal plant known for its adaptogenic, anti-inflammatory and neuroprotective properties. The withanolides it contains have a...

Back to Top